WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19

Must Read

How To Block Your Bank Account And SIM Card In Case Of Emergency

Losing your phone and wallet or having them stolen can be very frustrating. However, in case that happens to...

List of First Bank of Nigeria Sort Codes in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...

List of United Bank for Africa (UBA) Sort Codes & Branches (with addresses) in Nigeria

The sort code is a number that usually identifies both the bank and the branch where an account is held. The sort...
- Advertisement -

The drug is no longer a research priority; resources should focus on other more promising drugs to prevent covid-19

The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19 say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.

Their strong recommendation is based on high certainty evidence from six randomised controlled trials involving over 6,000 participants with and without known exposure to a person with the covid-19 infection.

WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19 Brandspurng

High certainty evidence showed that hydroxychloroquine had no meaningful effect on death and admission to hospital, while moderate certainty evidence showed that hydroxychloroquine had no meaningful effect on laboratory-confirmed covid-19 infection and it probably increases the risk of adverse effects.

As such, the panel considers that this drug is no longer a research priority and that resources should be used to evaluate other more promising drugs to prevent covid-19.

- Advertisement -

This guideline applies to all individuals who do not have covid-19, regardless of their exposure to a person with the covid-19 infection.

WHO to investigate allegations of sexual exploitation and abuse in Ebola response in the Democratic Republic of the Congo

The panel judged that almost all people would not consider this drug worthwhile, and also decided that factors such as resources, feasibility, acceptability, and equity for countries and healthcare systems were unlikely to alter the recommendation.

Read Also:  Market Cap of Three Leading Pharma Companies Jumped by $27bn in 2020, Roche Holding the Biggest Winner

Today’s recommendation is the first version of a living guideline for drugs to prevent covid-19, developed by the World Health Organization with the methodological support of the MAGIC Evidence Ecosystem Foundation. Its aim is to provide trustworthy guidance on the management of covid-19 and help doctors make better decisions with their patients.

- Advertisement -
Read Also:  I’m just a normal teenager living with HIV

Living guidelines are useful in fast-moving research areas like covid-19 because they allow researchers to update previously vetted and peer-reviewed evidence summaries.

New recommendations for other preventive drugs for covid-19 will be added to this guideline as more evidence becomes available.

- Advertisement -
WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19 - Brand SpurWHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19 - Brand Spur

Subscribe to BrandSpur Ng

Subscribe for latest updates. Signup to best of brands and business news, informed analysis and opinions among others that can propel you, your business or brand to greater heights.

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19 - Brand SpurWHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19 - Brand Spur

Latest News

LafargeHolcim Proposes Reducing Company Name To Holcim

The world’s largest cement maker, LafargeHolcim is proposing to simplify its name to Holcim Limited, reverting to the name...
- Advertisement -
BrandsPur Weekly Cartoons
- Advertisement -WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19 - Brand SpurWHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19 - Brand Spur